Health Economics and Outcomes Research (HEOR) Services Market Size, Share and Growth Outlook, 2026

Health Economics and Outcomes Research (HEOR) Services Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Health Economics and Outcomes Research (HEOR) Services Market size is forecast to increase from $2.11 Billion in 2026 to $5.77 Billion in 2034 at a CAGR of 13.4% between 2026 and 2034.

The Health Economics and Outcomes Research (HEOR) Services market report provides detailed analysis and outlook of Health Economics and Outcomes Research (HEOR) Services segments including By Service (Economic Modelling, Real-World Data Analytics & Information Systems, Clinical Outcomes Research, Market Access & Reimbursement), By Service Provider (Consultancies, Contract Research Organizations ), By End User (Biotech & Pharma Companies, Healthcare Providers, Government & Health Technology Assessment, Healthcare Payers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Health Economics and Outcomes Research (HEOR) Services Industry Overview

Regulatory Transformation Reshaping Health Economics and Outcomes Research

The Health Economics and Outcomes Research (HEOR) services industry is undergoing significant evolution as healthcare systems, regulatory authorities, and life sciences organizations place greater emphasis on demonstrating clinical value, economic impact, and real-world effectiveness of healthcare interventions. HEOR services have become essential for pharmaceutical companies, biotechnology developers, healthcare providers, and payers seeking evidence-based insights that support reimbursement decisions, market access strategies, and health technology evaluations. The increasing availability of real-world data, advanced analytics, and artificial intelligence technologies is transforming how HEOR professionals assess treatment outcomes, patient populations, and long-term healthcare value across global markets.

Centralized Health Technology Assessment Driving New Evidence Requirements

A major development influencing the HEOR services landscape is the implementation of the European Union’s centralized Health Technology Assessment framework. Under the new regulatory structure, biopharmaceutical companies and HEOR consultancies are required to submit standardized clinical outcomes dossiers through a unified European assessment process rather than addressing separate country-specific requirements. This shift is compelling organizations to incorporate health economics planning and real-world evidence generation earlier within the drug development lifecycle. HEOR teams are increasingly adapting modeling methodologies, comparative effectiveness assessments, and economic evaluation frameworks to align with harmonized evidence requirements. The centralized approach is expected to increase consistency in health technology evaluations while elevating the strategic importance of HEOR services throughout product development and commercialization activities.

Real-World Data Networks and Artificial Intelligence Enhancing Analytical Capabilities

The expansion of large-scale health data resources is creating new opportunities for advanced health economics research. The European Medicines Agency expanded the Data Analysis and Real World Interrogation Network, providing validated HEOR professionals with secure access to multinational electronic health records and patient registry datasets. These resources support the evaluation of long-term safety outcomes, treatment effectiveness, and economic utility for advanced therapeutics and biologics. Simultaneously, the International Society for Pharmacoeconomics and Outcomes Research introduced updated professional competencies focused on the application of generative artificial intelligence and machine learning within health economics. The guidance aims to standardize the use of predictive analytics for claims database analysis, management of incomplete clinical data, and automated economic simulation modeling. Together, these developments are strengthening the role of real-world evidence, advanced analytics, and artificial intelligence in supporting more sophisticated HEOR research and healthcare decision-making.

Health Economics and Outcomes Research (HEOR) Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Health Economics and Outcomes Research (HEOR) Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IQVIA Holdings Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, PPD (Thermo Fisher Scientific Inc.), Charles River Laboratories International, Inc., RTI Health Solutions, Analysis Group, Inc., Lumanity Inc., Evidera (PPD / Thermo Fisher Scientific Inc.). The Health Economics and Outcomes Research (HEOR) Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Health Economics and Outcomes Research (HEOR) Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Health Economics and Outcomes Research (HEOR) Services Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Health Economics and Outcomes Research (HEOR) Services companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Health Economics and Outcomes Research (HEOR) Services markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Health Economics and Outcomes Research (HEOR) Services Market Competitive Benchmarking and Company Analysis

Leading companies in Health Economics and Outcomes Research (HEOR) Services industry include- IQVIA Holdings Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, PPD (Thermo Fisher Scientific Inc.), Charles River Laboratories International, Inc., RTI Health Solutions, Analysis Group, Inc., Lumanity Inc., Evidera (PPD / Thermo Fisher Scientific Inc.). The Health Economics and Outcomes Research (HEOR) Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Health Economics and Outcomes Research (HEOR) Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Health Economics and Outcomes Research (HEOR) Services market remains one of the strongest-performing segments in the country.
The US Health Economics and Outcomes Research (HEOR) Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Health Economics and Outcomes Research (HEOR) Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Health Economics and Outcomes Research (HEOR) Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Health Economics and Outcomes Research (HEOR) Services markets

Canada's strong Health Economics and Outcomes Research (HEOR) Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Health Economics and Outcomes Research (HEOR) Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Health Economics and Outcomes Research (HEOR) Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Health Economics and Outcomes Research (HEOR) Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Health Economics and Outcomes Research (HEOR) Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Health Economics and Outcomes Research (HEOR) Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Health Economics and Outcomes Research (HEOR) Services market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Health Economics and Outcomes Research (HEOR) Services sales through 2034

France Health Economics and Outcomes Research (HEOR) Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Health Economics and Outcomes Research (HEOR) Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Health Economics and Outcomes Research (HEOR) Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Health Economics and Outcomes Research (HEOR) Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Health Economics and Outcomes Research (HEOR) Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Health Economics and Outcomes Research (HEOR) Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Health Economics and Outcomes Research (HEOR) Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Health Economics and Outcomes Research (HEOR) Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Health Economics and Outcomes Research (HEOR) Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Health Economics and Outcomes Research (HEOR) Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Health Economics and Outcomes Research (HEOR) Services Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Health Economics and Outcomes Research (HEOR) Services Market Segmentation

By Service
Economic Modelling
Real-World Data Analytics & Information Systems
Clinical Outcomes Research
Market Access & Reimbursement
By Service Provider
Consultancies
Contract Research Organizations
By End User
Biotech & Pharma Companies
Healthcare Providers
Government & Health Technology Assessment
Healthcare Payers

Top Companies in Health Economics and Outcomes Research (HEOR) Services Industry

IQVIA Holdings Inc.
ICON plc
Syneos Health, Inc.
Parexel International Corporation
PPD (Thermo Fisher Scientific Inc.)
Charles River Laboratories International, Inc.
RTI Health Solutions
Analysis Group, Inc.
Lumanity Inc.
Evidera (PPD / Thermo Fisher Scientific Inc.)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025